Interacting Drugs |
Fosamprenavir vs HMG-CoA Reductase Inhibitors |
Security Level |
 |
Mechanism |
HMG-CoA Reductase Inhibitors: Protease Inhibitors may increase the serum concentration of HMG-CoA Reductase Inhibitors. Limited data suggest pravastatin may slightly decrease protease inhibitor concentrations. |
Management |
Lovastatin and simvastatin are contraindicated with protease inhibitors; also, avoid rosuvastatin with indinavir. Use lowest possible HMG-CoA reductase inhibitor dose and monitor for signs of toxicity if these agents are used concomitantly. Exceptions: Fluvastatin. |
Fosamprenavir vs HMG-CoA Reductase Inhibitors
Post Review about Fosamprenavir vs HMG-CoA Reductase Inhibitors Click here to cancel reply.
Other Interactions of Fosamprenavir
Other Interactions of HMG-CoA Reductase Inhibitors
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.